36 results on '"Trullenque R"'
Search Results
2. S-Adenosyl-L-Methionine Prevents Intracellular Glutathione Depletion by GSH-Depleting Drugs in Rat and Human Hepatocytes
- Author
-
Jover, R., Ponsoda, X., Fabra, R., Trullenque, R., Gómez-Lechón, M. J., and Castell, J. V.
- Published
- 1992
- Full Text
- View/download PDF
3. Isolation, Culture and Use of Human Hepatocytes in Drug Research
- Author
-
GOMEZLECHON, M, primary, DONATO, T, additional, PONSODA, X, additional, CASTELL, J, additional, FABRA, R, additional, and TRULLENQUE, R, additional
- Published
- 1996
- Full Text
- View/download PDF
4. Intrahepatic sclerosing cholangitis
- Author
-
Montalva, E., Vazquez, A., Artigues, E., Peiro, F., Alberola, A., Garcia-Coret, M.J., Fabra, R., and Trullenque, R.
- Published
- 1998
5. The treatment of splenic injuries: our experience
- Author
-
Montalva, E., Vazquez, A., Artigues, E., and Trullenque, R.
- Published
- 1998
6. General: Surgical pathology in the octogenarian patient: an analysis of our experience in the last 3 years of 583 cases
- Author
-
Munoz-Alonso, C., Asensi-Perez, J., Villalba-Caballero, R., Davila-Dorta, D., Garay-Burdeos, M., and Peris-Trullenque, R.
- Published
- 1995
7. Breast: The relationship between the Bloom index and hormone receptors in female breast cancer
- Author
-
Fuster, E., Munoz, Fuster, C.A., Garcia-Coret, M.J., Garcia-Vilanova, A., Lluch, A., Davila, D., Garcia-Vilanova Comas, A., Asensi, J., Checa, F., and Trullenque, R.
- Published
- 1995
8. Breast: The relationship between the tumour staging (1987) and hormone receptor status in female breast cancer
- Author
-
Fuster, E., Munoz, Garcia-Coret, M.J., Fuster, C.A., Lluch, A., Garcia-Vilanova, A., Davila, D., Garcia-Vilanova Comas, A., Todoli, J., Checa, F., and Trullenque, R.
- Published
- 1995
9. Appendix: Appendicular mucocele
- Author
-
Garcia-Coret, M.I., Munoz, C., Villalba, F., Davila, D., Asensi, J., Garcia-Monco, P., and Trullenque, R.
- Published
- 1995
10. Problemas actuales de la formación en cirugía laparoscópica
- Author
-
Trullenque, J.R., Martí, E., Torres, T., Richart, J.M., Gómez, S.A., and Trullenque, R.
- Published
- 2001
- Full Text
- View/download PDF
11. Initial results of the oesophageal and gastric cancer registry from the Comunidad Valenciana
- Author
-
Escrig J, Mingol F, Marti R, Puche J, Trullenque R, Barreras JA, Asencio F, Aguilo J, Navarro JM, Alberich C, Salas D, Lacueva F, and en representacion del grupo RECEG-CV
- Subjects
Cáncer de esófago, Cáncer gástrico, Gastric cancer, Indicadores, Mortalidad postoperatoria, Oesophageal cancer, Outcomes, Postoperative mortality, Registro, Registry ,humanities - Abstract
Aims: To evaluate the initial results of the oesophagogastric cancer registry developed for the Sociedad Valenciana de Cirugia and the Health Department of the Comunidad Valenciana (Spain). Methods: Fourteen of the 24 public hospitals belonging to the Comunidad Valenciana participated. All patients with diagnosis of oesophageal or gastric carcinomas operated from January 2013 to December 2014 were evaluated. Demographic, clinical and pathological data were analysed. Results: Four hundred and thirty-four patients (120 oesophageal carcinomas and 314 gastric carcinomas) were included. Only two hospitals operated more than 10 patients with oesophageal cancer per year. Transthoracic oesophaguectomy was the most frequent approach (84.2%) in tumours localized within the oesophagus. A total gastrectomy was performed in 50.9% patients with gastroesophageal junction (GOJ) carcinomas. Postoperative 30-day and 90-day mortality were 8% and 11.6% in oesophageal carcinoma and 5.9 and 8.6% in gastric carcinoma. Before surgery, middle oesophagus carcinomas were treated mostly (76,5%) with chemoradiotherapy. On the contrary, lower oesophagus and GOJ carcinomas were treated preferably with chemotherapy alone (45.5 and 53.4%). Any neoadjuvant treatment was administered to 73.6% of gastric cancer patients. Half patients with oesophageal carcinoma or gastric carcinoma received no adjuvant treatment. Conclusions: This registry revealed that half patients with oesophageal cancer were operated in hospitals with less than 10 cases per year at the Comunidad Valenciana. Also, it detected capacity improvement for some clinical outcomes of oesophageal and gastric carcinomas. (C) 2017 AEC. Published by Elsevier Espana, S.L.U. All rights reserved.
- Published
- 2017
12. Culture of human hepatocytes from small surgical liver biopsies. Biochemical characterization and comparison with in vivo
- Author
-
Trullenque R, P. Lopez, José V. Castell, T. Donato, Amparo Larrauri, Giménez P, Fabra R, Maria-José Gómez-Lechón, and Angel Montoya
- Subjects
medicine.medical_specialty ,Glycogenolysis ,Biopsy ,Clinical Biochemistry ,Plant Science ,In Vitro Techniques ,Biology ,Glucagon ,Dexamethasone ,Mixed Function Oxygenases ,chemistry.chemical_compound ,Cytochrome P-450 Enzyme System ,Internal medicine ,Cell Adhesion ,medicine ,Humans ,Urea ,Cells, Cultured ,medicine.diagnostic_test ,Glycogen ,Gluconeogenesis ,Albumin ,Blood Proteins ,Cell Biology ,Glutathione ,Microbial Collagenase ,Endocrinology ,medicine.anatomical_structure ,Liver ,chemistry ,Cell culture ,Glycogenesis ,Liver biopsy ,Hepatocyte ,Glycolysis ,Biotechnology ,Developmental Biology - Abstract
High yields of human hepatocytes (up to 23×106 viable cells/g) were obtained from small surgical liver biopsies (1 to 3 g) by a two-step collagenase microperfusion method. Cell viability was about 95%, attachment efficiency of hepatocytes seeded on fibronectin-coated plates was 80% within 1 h after plating, and cells survived for about 2 wk in serum-free Ham’s F12 containing 0.2% bovine serum albumin, 10−8 M insulin, and 10−8 M dexamethasone. To evaluate the metabolism of human hepatocytes in serum-free conditions, we measured their most characteristic biochemical functions and compared them to those reported for human liver. After 24 h in culture, glycogen content was 1250±177 nmol glucose/mg cell protein and remained stable for several days. Gluconeogenesis from lactate in hormone-free media was (3.50±0.17 nmol glucose·mg−1·min−1) similar to that reported for human liver. Insulin at 10−8 M activated glycolysis (×1.40) and glycogenesis (×1.34), and glucagon at 10−9 M stimulated gluconeogenesis (×1.35) and glycogenolysis (×2.18). Human hepatocytes synthesized albumin, transferrin, fibrinogen, α1-antitrypsin, α1-antichymotrypsin, α1-acid glycoprotein, haptoglobin, α2-macroglobulin, and plasma fibronectin and excreted them to the culture medium. Maximum protein synthesis was stimulated by 10−9 M dexamethasone. Basal urea synthesis oscillated between 2.5 and 3.5 nmol·mg−1 cell protein·min−1, about 5 times the value estimated for human liver. Cytochrome P-450 decreased in culture but it was still 20% of freshly isolated hepatocytes by Day 5 in culture. In addition, ethoxycumarin-O-deethylase and aryl hydrocarbon hydroxylase could be induced in vitro by treatment with methyl cholanthrene. Glutathione levels were similar to those reported for human liver (35 nmol·mg−1). The results of our work show that adult human hepatocytes obtained from small surgical biopsies and cultured in chemically defined conditions express their most important metabolic functions to an extent that is similar to that reported for adult human liver.
- Published
- 1990
- Full Text
- View/download PDF
13. Pancreatic function after severe acute biliary pancreatitis: the role of necrosectomy
- Author
-
J. Calvete, Pareja E, Luis Sabater, Sastre J, Oviedo M, Camps B, E. Artigues, Luis Aparisi, Trullenque R, and Lledó S
- Subjects
Blood Glucose ,Male ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Biliary Tract Diseases ,Gastroenterology ,Severity of Illness Index ,Excretion ,Cohort Studies ,Endocrinology ,Pancreatectomy ,Internal medicine ,Internal Medicine ,medicine ,Pancreatic function ,Endocrine system ,Humans ,Biliary pancreatitis ,Prospective Studies ,Prospective cohort study ,Pancreas ,Aged ,Hepatology ,business.industry ,Pancreatitis, Acute Necrotizing ,Insulin ,Glucose Tolerance Test ,Middle Aged ,medicine.disease ,Steatorrhea ,Pancreatic Function Tests ,Pancreatitis ,Female ,medicine.symptom ,business - Abstract
OBJECTIVES To investigate the recovery of pancreatic function after severe acute biliary pancreatitis (ABP), especially the influence of necrosectomy on endocrine and exocrine functions. METHODS Prospective cohort study including 39 patients with severe ABP. According to need or no need for surgical necrosectomy, patients were further subdivided into 2 groups. Functional pancreatic evaluation was carried out 12 months after the ABP episode. Endocrine function was evaluated by an oral glucose tolerance test and exocrine function by fecal fat excretion, fecal chymotrypsin (FQ), and secretin-cerulein tests (SCT). RESULTS Most of the patients with necrosectomy had an abnormal exocrine pancreatic function, with steatorrhea in 25%. In the group without surgery, exocrine function was pathologic in only 13.3% and there were no cases of steatorrhea. Endocrine function was pathologic in 75% of patients undergoing necrosectomy versus 26.7% in the nonoperated group. In this latter group, the patients with abnormal endocrine function did not require insulin therapy, while in 33.3% of patient in the necrosectomy group insulin was necessary. CONCLUSIONS In our homogeneous series of severe ABP, necrosectomy impaired significantly pancreatic endocrine and exocrine function. On the other hand, most patients with the same origin and severity index, but without surgical debridement, maintained normal pancreatic function.
- Published
- 2004
14. Oncostatin M down-regulates basal and induced cytochromes P450 in human hepatocytes
- Author
-
Mi, Guillén, M. Teresa Donato, Jover R, Jv, Castell, Fabra R, Trullenque R, and Mj, Gómez-Lechón
- Subjects
Adult ,Male ,Down-Regulation ,Proteins ,Oncostatin M ,Middle Aged ,Growth Inhibitors ,Mixed Function Oxygenases ,Cytochrome P-450 Enzyme System ,Liver ,Cytochrome P-450 CYP1A2 ,Enzyme Induction ,Cytochrome P-450 CYP3A ,Cytokines ,Humans ,Female ,Peptides ,Nitrites ,Aged - Abstract
The effects of oncostatin M on the expression of different cytochrome P450 (CYP) isozymes has been investigated in human hepatocytes. The dose-response and time-course analyses of effects on CYP1A2 and CYP3A4 isozymes revealed that maximal inhibition was reached after 48 hr of exposure of human hepatocytes to 25 units/ml oncostatin M. Reductions in CYP1A2 and CYP3A4 activity produced by oncostatin M correlated with decreases in protein content, de novo protein synthesis and specific mRNA levels, thus suggesting that oncostatin M could down-regulate CYP expression at the transcriptional level. The inhibitory potency of oncostatin M on CYP expression was compared with that of other cytokines belonging to the interleukin-6 receptor family (interleukin-6, interleukin-11 and leukemia inhibitory factor), and interferon-gamma, which is recognized to inhibit human CYP expression, and granulocyte colony-stimulating factor, a cytokine that shares structural homology with the interleukin-6 family but has a different transduction signal. Maximal reductions in CYP1A2 activity were reached after 48 hr of treatment with cytokines. At that time, oncostatin M showed the highest inhibitory effects on CYP1A2 activity (38% of control), followed by interferon (49% of control) and interleukin-6 (60% of control), whereas minor effects were produced by the other cytokines (74-80%). Comparable decreases were observed for CYP2A6, CYP2B6 and CYP3A4 activities. Enzymatic activity and de novo protein synthesis of 3-methylcholanthrene-induced CYP1A2 and dexamethasone-induced CYP3A4 were also reduced to a much greater extent by oncostatin M than by other cytokines. The results show that oncostatin M is the most effective cytokine in down-regulating CYP isozymes in human hepatocytes, and its effects were evident even after removal of the cytokine from the culture medium.
- Published
- 1998
15. Pancreatic Function After Severe Acute Biliary Pancreatitis: The Role of Necrosectomy
- Author
-
Sabater, L., primary, Pareja, E., additional, Aparisi, L., additional, Calvete, J., additional, Camps, B., additional, Sastre, J., additional, Artigues, E., additional, Oviedo, M., additional, Trullenque, R., additional, and Lledó, S., additional
- Published
- 2004
- Full Text
- View/download PDF
16. Cell cycle progression proteins (cyclins), oncogene expression, and signal transduction during the proliferative response of human hepatocytes to hepatocyte growth factor
- Author
-
Gomez-Lechon, M J, primary, Guillen, I, additional, Ponsoda, X, additional, Fabra, R, additional, Trullenque, R, additional, Nakamura, T, additional, and Castell, J V, additional
- Published
- 1996
- Full Text
- View/download PDF
17. Drug biotransformation by human hepatocytes. In vitro/in vivo metabolism by cells from the same donor
- Author
-
Ponsoda, X., Pareja, E., Gomez-Lechon, M. J., Fabra, R., Carrasco, E., Trullenque, R., and Castell, J. V.
- Published
- 2001
- Full Text
- View/download PDF
18. Oncostatin M Down-regulates Basal and Induced Cytochromes P450 in Human Hepatocytes1
- Author
-
Guillén, M. Isabel, Donato, M. Teresa, Jover, Ramiro, Castell, JoséV., Fabra, R., Trullenque, R., and Gómez-Lechón, M. José
- Abstract
The effects of oncostatin M on the expression of different cytochrome P450 (CYP) isozymes has been investigated in human hepatocytes. The dose-response and time-course analyses of effects on CYP1A2 and CYP3A4 isozymes revealed that maximal inhibition was reached after 48 hr of exposure of human hepatocytes to 25 units/ml oncostatin M. Reductions in CYP1A2 and CYP3A4 activity produced by oncostatin M correlated with decreases in protein content, de novoprotein synthesis and specific mRNA levels, thus suggesting that oncostatin M could down-regulate CYP expression at the transcriptional level. The inhibitory potency of oncostatin M on CYP expression was compared with that of other cytokines belonging to the interleukin-6 receptor family (interleukin-6, interleukin-11 and leukemia inhibitory factor), and interferon-γ, which is recognized to inhibit human CYP expression, and granulocyte colony-stimulating factor, a cytokine that shares structural homology with the interleukin-6 family but has a different transduction signal. Maximal reductions in CYP1A2 activity were reached after 48 hr of treatment with cytokines. At that time, oncostatin M showed the highest inhibitory effects on CYP1A2 activity (38% of control), followed by interferon (49% of control) and interleukin-6 (60% of control), whereas minor effects were produced by the other cytokines (74–80%). Comparable decreases were observed for CYP2A6, CYP2B6 and CYP3A4 activities. Enzymatic activity and de novoprotein synthesis of 3-methylcholanthrene-induced CYP1A2 and dexamethasone-induced CYP3A4 were also reduced to a much greater extent by oncostatin M than by other cytokines. The results show that oncostatin M is the most effective cytokine in down-regulating CYP isozymes in human hepatocytes, and its effects were evident even after removal of the cytokine from the culture medium.
- Published
- 1998
- Full Text
- View/download PDF
19. Toxicity of paracetamol in human hepatocytes. Comparison of the protective effects of sulfhydryl compounds acting as glutathione precursors
- Author
-
Amparo Larrauri, Fabra, R., Gómez-Lechón, M. J., Trullenque, R., and Castell, J. V.
20. Hepatotoxicity of the opioids morphine, heroin, meperidine, and methadone to cultured human hepatocytes
- Author
-
Gomez-Lechon, M. J., Xavier Ponsoda, Jover, R., Fabra, R., Trullenque, R., and Castell, J. V.
21. Use of human hepatocytes in culture to predict the potential risk of hepatotoxicity of drugs,USO DE HEPATOCITOS HUMANOS EN CULTIVO PARA LA PREDICCION DEL RIESGO POTENCIAL DE HEPATOTOXICIDAD DE MEDICAMENTOS
- Author
-
Vicente Castell, J., M. Teresa Donato, Larrauri, A., Fabra, R., Trullenque, R., and Gomez-Lechon, M. J.
22. Oncostatin M down-regulates basal and induced cytochromes P450 in human hepatocytes
- Author
-
Guillén, M. I., Donato, M. T., RAMIRO JOVER, Castell, J. V., Fabra, R., Trullenque, R., and Gómez-Lechón, M. J.
23. The effects of buprenorphine on the metabolism of human hepatocytes
- Author
-
Ponsoda, X., Jover, R., Gómez-Lechón, M.J., Fabra, R., Trullenque, R., and Castell, J.V.
- Published
- 1991
- Full Text
- View/download PDF
24. Enhancing the accuracy of mid-infrared spectroscopy-based liver steatosis quantification using digital image analysis as a reference.
- Author
-
Rienda I, Ten-Doménech I, Moro E, Moreno-Torres M, Pérez-Rojas J, Pareja E, Pérez-Rubio Á, Trullenque R, Jover R, Lendl B, Pérez-Guaita D, Kuligowski J, Castell JV, and Quintás G
- Subjects
- Humans, Spectroscopy, Fourier Transform Infrared methods, Reproducibility of Results, Spectrophotometry, Infrared, Discriminant Analysis, Least-Squares Analysis, Fatty Liver diagnostic imaging, Fatty Liver pathology
- Abstract
The assessment of liver steatosis is crucial in both hepatology and liver transplantation (LT) surgery. Steatosis can negatively impact the success of LT. Steatosis is a factor for excluding donated organs for LT, but the increasing demand for transplantable organs has led to the use of organs from marginal donors. The current standard for evaluating steatosis is a semi-quantitative grading based on the visual examination of a hematoxylin and eosin (H&E)-stained liver biopsy, but this method is time-consuming, subjective, and lacks reproducibility. Recent research has shown that infrared (IR) spectroscopy could be used as a real-time quantitative tool to assess steatosis during abdominal surgery. However, the development of IR-based methods has been hindered by the lack of appropriate quantitative reference values. In this study, we developed and validated digital image analysis methods for the quantitation of steatosis in H&E-stained liver sections using univariate and multivariate strategies including linear discriminant analysis (LDA), quadratic DA, logistic regression, partial least squares-DA (PLS-DA), and support vector machines. The analysis of 37 tissue samples with varying grades of steatosis demonstrates that digital image analysis provides accurate and reproducible reference values that improve the performance of IR spectroscopic models for steatosis quantification. A PLS model in the 1810-1052 cm
-1 region using first derivative ATR-FTIR spectra provided RMSECV = 0.99%. The gained improvement in accuracy critically enhances the applicability of Attenuated Total Reflectance-Fourier Transform Infrared (ATR-FTIR) to support an objective graft evaluation at the operation room, which might be especially relevant in cases of marginal liver donors to avoid unnecessary graft explantation.- Published
- 2023
- Full Text
- View/download PDF
25. Acute biliary pancreatitis: does the pancreas change morphologically in the long term?
- Author
-
Pareja E, Mir J, Artigues E, Martínez V, Fabra R, and Trullenque R
- Subjects
- Acute Disease, Adult, Aged, Aged, 80 and over, Biliary Tract Diseases complications, Female, Humans, Male, Middle Aged, Pancreatic Ducts pathology, Pancreatitis etiology, Prospective Studies, Secretin physiology, Pancreas pathology, Pancreatitis pathology
- Abstract
The objective of the study was to assess by means of magnetic resonance cholangiopancreatography whether acute biliary pancreatitis leads to alterations in pancreatic morphology and the main pancreatic duct; to establish whether such alterations are related to the severity of the acute episode and if they are to be considered as sequelae of the illness or on the contrary the findings constitute diagnostic morphological criteria of chronic pancreatitis. Forty patients with acute biliary pancreatitis were prospectively and consecutively studied, 15 female (37.5%) and 25 male (62.5%). During the acute phase the severity was assessed according to the Atlanta criteria. During subsequent follow-up,we assessed the morphology of the gland and the main pancreatic duct with magnetic resonance cholangiopancreatography 5 years after the episode of pancreatitis, and compared the findings with the findings from a control group. We administered secretin in 16 of the study group cases when visualization of the duct was incomplete or absent. The statistical study of diameter and length showed significant differences in the main pancreatic duct of the case and control groups. No relationship was found between the severity of the illness and morphological alterations of the pancreas after pancreatitis. The statistical analysis, which compared the diameter and the length of the main pancreatic duct before and after the injection of secretin in the study group showed significant differences. We conclude that after acute biliary pancreatitis, in the long term, scarring lesions are detected, which are considered to be sequelae of the acute episode, unrelated to its severity. Secretin stimulation improved visualization of the main pancreatic duct in the magnetic resonance cholangiopancreatography., (Copyright 2005 S. Karger AG, Basel and IAP)
- Published
- 2005
- Full Text
- View/download PDF
26. Main pancreatic duct: morphlogy after acute biliary pancreatitis with magnetic resonance cholangiopancreatography after secretin stimulation.
- Author
-
Pareja E, Artigues E, Mir J, Fabra R, Martínez V, Vázquez A, and Trullenque R
- Subjects
- Acute Disease, Adult, Aged, Aged, 80 and over, Cholangiopancreatography, Endoscopic Retrograde, Female, Humans, Magnetic Resonance Angiography, Male, Middle Aged, Pancreas pathology, Pancreatic Ducts metabolism, Pancreatitis, Acute Necrotizing metabolism, Pancreatic Ducts pathology, Pancreatitis, Acute Necrotizing pathology, Secretin metabolism
- Abstract
Objective: to assess whether a magnetic resonance cholangiopancreatography performed after an acute biliary pancreatitis leads to pancreatic morphological alterations and if secretin stimulation influences the visualization of the pancreatic tree., Method: forty patients with acute biliary pancreatitis, 25 female (62,5/) and 15 male (37,5/), 27 mild and 13 severe, were prospectively and consecutively studied. All patients had undergone cholecystectomy. No altered pancreatic functions were observed. Morphology of the pancreas and of the main pancreatic duct were assessed by magnetic resonance cholangiopancreatography five years after the episode of pancreatitis and a comparative study between patients and case controls was carried out. Secretin was given in 16 cases in whom the visualization of the duct was incomplete or absent. Ductal morphology before and after secretin stimulation was compared., Results: significant differences were observed when the diameter and length of the main pancreatic duct were compared in patients and control cases and was completely visualized in 60% of the cases, and could be seen in all patients after secretin stimulation. The comparative statistical analysis of the length and diameter of the pancreatic duct before and after the secretin stimulation showed significant differences., Conclusion: acute biliary pancreatitis leads to morphological alterations, regarded as scar lesions which do not become chronic. Secretin stimulation improves the visualization of the main pancreatic duct.
- Published
- 2003
27. Exocrine pancreatic changes following acute attack of biliary pancreatitis.
- Author
-
Pareja E, Artigues E, Aparisi L, Fabra R, Martínez V, and Trullenque R
- Subjects
- APACHE, Acute Disease, Amylases blood, Cholecystectomy, Chymotrypsin blood, Feces chemistry, Female, Follow-Up Studies, Gallbladder Diseases diagnostic imaging, Gallbladder Diseases surgery, Humans, Lipids analysis, Male, Middle Aged, Pancreas diagnostic imaging, Pancreatitis diagnostic imaging, Prognosis, Retrospective Studies, Tomography, X-Ray Computed, Gallbladder Diseases diagnosis, Pancreas pathology, Pancreatitis diagnosis
- Abstract
Following the Cambridge and Marseilles Symposia, functional recovery of the pancreas occurs if the primary cause and complications of the disease have been eliminated. However, recent research showed contradictory results, owing to the difference in diagnostic methods and the proportion of patients studied in relation to the etiologic factor and severity of the disease, as well as the differences in the tests utilized. Sixty-three consecutive patients with acute biliary pancreatitis were prospectively studied. Seventeen were men (27%) and 46 were women (73%), with an average age of 62.3 years, 45 were mild cases and 18 were severe. All patients underwent a cholecystectomy. No patient in this series underwent necrosectomy. During the acute phase, severity was evaluated following the Atlanta criteria as well as the existence of necrosis and its percentage by means of dynamic computed tomography (CT). During the follow-up, different tests were used to assess the pancreatic exocrine function, 1 month, 6 months and 1 year after the acute pancreatitis (AP) episode. The possible existence of pancreatic exocrine insufficiency following biliary origin AP as well as whether this possible deficit was related to the severity of the episode was investigated. We found no such insufficiency 1 year after the episode, and no link with the severity of the episode., (Copyright 2002 S. Karger AG, Basel and IAP)
- Published
- 2002
- Full Text
- View/download PDF
28. Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community.
- Author
-
Oliva MR, Ripoll F, Muñiz P, Iradi A, Trullenque R, Valls V, Drehmer E, and Sáez GT
- Subjects
- 8-Hydroxy-2'-Deoxyguanosine, Adenocarcinoma metabolism, Adult, Aged, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 18, Chromosomes, Human, Pair 22, Chromosomes, Human, Pair 5, Colorectal Neoplasms metabolism, DNA Mutational Analysis, DNA, Neoplasm genetics, Deoxyguanosine analogs & derivatives, Deoxyguanosine chemistry, Female, Gene Amplification, Genes, p53, Genetic Markers, Glutathione metabolism, Heterozygote, Humans, Lipid Peroxides metabolism, Male, Middle Aged, Oxidation-Reduction, Polymorphism, Single-Stranded Conformational, Proto-Oncogene Proteins genetics, Proto-Oncogene Proteins c-mdm2, Sequence Deletion, Spain, Adenocarcinoma genetics, Colorectal Neoplasms genetics, Nuclear Proteins
- Abstract
Deletions of loci on chromosomes 5q, 17p, 18q, and 22q, together with the incidence of p53 mutations and amplification of the double minute-2 gene were investigated in the sporadic colorectal tumors of 44 patients from a Spanish community. Chromosome deletions were analyzed by means of loss of heterozygosity analysis using a restriction fragment length polymorphism assay. Allelic losses were also detected by polymerase chain reaction (PCR)-single-stranded conformation polymorphism (SSCP) analysis of a polymorphic site in intron 2 of the p53 gene. The percentages of genetic deletions on the screened chromosomes were 39.3% (5q), 58.3% (17p), 40.9% (18q), and 40% (22q). Mutations in p53 exons 2-9 were examined by PCR-SSCP analysis and direct sequencing of the mutated region. Twenty of 44 tumor samples (45.45%) showed mutations at various exons except for exons 2, 3, and 9, the most frequent changes being G-->T transversion and C-->T transition. Because oxygen-free radicals play a role in the carcinogenesis process, we evaluated the oxidative status of the colorectal tumors. Antioxidant activities, lipid peroxidation, and DNA-damaged product concentrations in colon tumors and normal mucosa were compared. In tumor tissues, superoxide dismutase and catalase decreased fourfold and twofold, respectively, whereas glutathione peroxidase and reduced glutathione increased threefold. Malondialdehyde and 8-hydroxy-2-deoxyguanosine (8-OHdG) levels were twofold higher in colorectal tumors than in normal mucosa. Seven of 10 DNA tumor samples (70%) showing higher values of 8-OHdG also had genetic alterations at different chromosomal loci. In these samples, the p53 gene was deleted or mutated in 71.4% of cases. We concluded that the observed changes in the oxidative metabolism of the tumor cells and the consecutive increase in DNA damage may potentiate the genomic instability of different chromosomal regions, leading to further cell malignancy and tumor expansion.
- Published
- 1997
29. [Multiple nosocomial infections. An incidence study].
- Author
-
de Juan García S, González Monte C, Pinazo Murria M, Prats Fornell J, Escoms Trullenque R, Piqueras Altabella R, Martínez Ruiz MJ, and Pérez Martín M
- Subjects
- Chi-Square Distribution, Confidence Intervals, Female, Hospital Departments statistics & numerical data, Humans, Incidence, Length of Stay statistics & numerical data, Longitudinal Studies, Male, Middle Aged, Spain epidemiology, Cross Infection epidemiology
- Abstract
Background: Some studies point out that around 30%-50% of the nosocomial infections (NI) are multiple (MNI) and are found in 21%-30% of the patients with NI. The significance of these data and their potential consequences have led the authors to perform this study., Patients and Methods: A longitudinal descriptive study was carried out on the incidence and characteristics of NI (MNI and single nosocomial infection [SNI]) in 26,977 patients admitted to a county hospital from 1991 to 1993., Results: NI was detected in 1,246 patients with 31% presenting MNI appearing in 15% of the patients. MNI predominated in males, had a mean age were 5 to 12 years higher than the patients with SNI with a mean hospital stay of between 13-28 days more than the SNI group. The MNI were significantly less frequent in the Urology, Gynecology and Obstetrics Departments and were more frequent in the Intensive Care Unit. The localization of the infection varied significantly among the patients with one or several infections. Bacteremia, pneumonia and soft tissue infections were significantly more frequent in MNI patients., Conclusions: Multiple nosocomial infections are frequent and their basic characteristics are significantly different from those of single nosocomial infections. The patients who acquire SNI should be carefully followed to avoid the appearance of MNI.
- Published
- 1996
30. [Solitary plasmocytoma of the cecum].
- Author
-
Bernal-Sprekelsen JC, Puchades F, Villalba F, Sabater F, García J, and Trullenque R
- Subjects
- Adult, Biopsy, Cecal Neoplasms diagnostic imaging, Cecal Neoplasms pathology, Cecum pathology, Colectomy, Colonoscopy, Diagnosis, Differential, Humans, Male, Plasmacytoma diagnostic imaging, Plasmacytoma pathology, Radiography, Cecal Neoplasms diagnosis, Plasmacytoma diagnosis
- Published
- 1996
31. Effects of hepatocyte growth factor on the growth and metabolism of human hepatocytes in primary culture.
- Author
-
Gómez-Lechón MJ, Castelli J, Guillén I, O'Connor E, Nakamura T, Fabra R, and Trullenque R
- Subjects
- Acute-Phase Reaction blood, Adult, Aged, Blood Proteins analysis, Cell Division drug effects, Cells, Cultured, DNA biosynthesis, Dose-Response Relationship, Drug, Female, Glycogen metabolism, Growth Substances pharmacology, Hormones pharmacology, Humans, Kinetics, Liver cytology, Male, Middle Aged, Recombinant Proteins, Hepatocyte Growth Factor pharmacology, Liver drug effects, Liver metabolism
- Abstract
The effect of recombinant human hepatocyte growth factor (h-rHGF), a potent mitogen for hepatocytes, was investigated in primary cultures of human hepatocytes. Here, we describe a series of experiments to investigate the kinetics of its mitogenic action, as well as its metabolic effects on cultured human hepatocytes. The h-rHGF is a potent signal for initiating DNA synthesis in human hepatocytes, with maximal stimulatory effects at 10 ng/mL (0.1 pmol/L). The kinetics of DNA synthesis showed a lag of about 48 to 72 hours, followed by a maximum at 96 hours. At least 48 hours of continuous exposure to h-rHGF are required to initiate DNA synthesis in quiescent human hepatocytes. Cell cycle analysis by flow cytometry showed that most of quiescent 2c cells have left G0/G1 and entered the cell cycle (S and G2/M phases) by 96 hours of continuous exposure to h-rHGF. When compared with other growth factors, h-rHGF was a much more potent mitogen. The effects of 10 ng/mL (0.1 pmol/L) h-rHGF on DNA synthesis were only achieved by 1.5 pmol/L epidermal growth factor (EGF), 0.1 mumol/L insulin, or 1 mumol/L glucagon. It is noteworthy that the effect of h-rHGF was potentiated by glucagon but not by insulin or EGF. The stimulatory effect of HGF on DNA synthesis was gradually inhibited by h-rHGF transforming growth factor beta (TGF-beta) in the range 1 to 10 ng/ml. The HGF also influenced the expression of other hepatic genes.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1995
32. Intracellular glutathione in human hepatocytes incubated with S-adenosyl-L-methionine and GSH-depleting drugs.
- Author
-
Ponsoda X, Jover R, Gómez-Lechón MJ, Fabra R, Trullenque R, and Castell JV
- Subjects
- Cells, Cultured, Dose-Response Relationship, Drug, Heroin toxicity, Humans, Liver cytology, Liver metabolism, Methadone toxicity, Acetaminophen toxicity, Ethanol toxicity, Glutathione metabolism, Liver drug effects, Narcotics toxicity, S-Adenosylmethionine pharmacology
- Abstract
The present study was undertaken to investigate (a) whether S-adenosyl-L-methionine (SAMe) added to culture medium can increase intracellular glutathione (GSH) levels in human hepatocytes and (b) whether SAMe can prevent the GSH depletion found in human hepatocytes incubated with GSH-depleting drugs (paracetamol, opiates, ethanol). Incubation of hepatocytes with increasing concentrations of SAMe resulted in a dose-dependent elevation of intracellular GSH content, which reached its maximum (35% increase) at 30 microM after 20 h. SAMe, as the only sulfur source in the medium, was efficient in repleting GSH-depleted hepatocytes following treatment with diethyl maleate. Incubation of human hepatocytes with SAMe attenuated the GSH depletion of cells incubated with toxic concentrations of paracetamol (2 mM), heroin (0.5 mM) and methadone (0.2 mM). A decrease in GSH due to exposure of hepatocytes to 50 mM ethanol was prevented when SAMe was simultaneously added to ethanol, and human hepatocytes maintained their GSH levels like non ethanol-treated cells. The experimental results of our work give the first direct evidence of the ability of exogenously administered SAMe to increase intracellular GSH levels in human hepatocytes and to prevent the GSH depletion caused by paracetamol, opiates and ethanol.
- Published
- 1991
- Full Text
- View/download PDF
33. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6.
- Author
-
Castell JV, Gómez-Lechón MJ, David M, Fabra R, Trullenque R, and Heinrich PC
- Subjects
- C-Reactive Protein genetics, C-Reactive Protein metabolism, Dexamethasone pharmacology, Fibrinogen metabolism, Humans, Interleukin-1 pharmacology, Liver pathology, RNA, Messenger metabolism, Serum Albumin metabolism, Tumor Necrosis Factor-alpha pharmacology, alpha 1-Antitrypsin metabolism, Acute-Phase Proteins biosynthesis, Acute-Phase Reaction metabolism, Interleukin-6 pharmacology, Liver metabolism
- Abstract
Human hepatocytes in primary culture were used as a model system to investigate the mechanism(s) involved in the induction of the acute-phase response in human liver. Hepatocytes were incubated with increasing amounts of recombinant human interleukin-1 beta, recombinant interleukin-6 and tumor necrosis factor-alpha. Synthesis of C-reactive protein was studied at the mRNA and protein levels. Only recombinant interleukin-6 was capable of inducing C-reactive protein-mRNA and C-reactive protein-protein synthesis. Also, fibrinogen and alpha-1-antitrypsin synthesis measured by immunoprecipitation with specific antisera increased in a dose-dependent, time-dependent manner, whereas albumin synthesis decreased to about 50% of controls. Maximal effects were observed at 100 to 300 units of recombinant interleukin-6/ml culture medium after 20 hr of incubation. Although the synthetic glucocorticoid dexamethasone slightly modulated the effect of recombinant interleukin-6, it was not an absolute requirement for the induction of acute-phase protein synthesis in human hepatocytes. In pulse-chase experiments it was shown that the time course of the disappearance of the acute-phase proteins from the cells and their appearance in the medium is not influenced by recombinant interleukin-6. This finding suggests that recombinant interleukin-6 exerts its regulatory effect on acute-phase protein synthesis at the pretranslational level.
- Published
- 1990
- Full Text
- View/download PDF
34. Toxicity of paracetamol in human hepatocytes. Comparison of the protective effects of sulfhydryl compounds acting as glutathione precursors.
- Author
-
Larrauri A, Fabra R, Gómez-Lechón MJ, Trullenque R, and Castell JV
- Subjects
- Acetylcysteine pharmacology, Cells, Cultured, Enzyme Induction, Humans, Liver analysis, Acetaminophen toxicity, Glutathione analysis, Liver drug effects, Sulfhydryl Compounds pharmacology
- Abstract
The hepatotoxicity of N-acetyl-p-aminophenol (acetaminophen, paracetamol) was investigated in hepatocyte cultures obtained from eight different human liver biopsies. Incubation of hepatocytes with paracetamol resulted in a dose- and time-dependent glutathione depletion. Glutathione decreased linearly for 8 h, reaching a minimum after 12 h of exposure. Cytotoxicity, assessed as loss of cellular protein from plates, was observed only when glutathione decreased below 20% for more than 12 h. However, in one donor, cytotoxicity was observed with even a moderate glutathione decrease. Prestimulation of hepatocytes with 1 mM phenobarbital or 2 microM methylcholanthrene for 48 h did not lead to a significant increase of paracetamol toxicity, although the glutathione levels in 3-methylcholanthrene-treated cells were somewhat lower. Several metabolic precursors were examined in vitro for their ability to increase intracellular glutathione and the results showed the following sequence: N-acetylcysteine greater than thioproline greater than cysteine greater than 2-oxo-4-thiazolidine carboxylic acid greater than methionine. However, only N-acetylcysteine, thioproline, and cysteine substantially increased glutathione levels when 1 mM paracetamol was present in the incubation medium and thus prevented its toxicity. N-acetylcysteine elevated glutathione even after 24 h of preexposure to paracetamol. The fact that cell damage did not correlate with glutathione levels in all human cultures suggests that glutathione depletion may not be the only determinant of paracetamol toxicity in human hepatocytes.
- Published
- 1987
35. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes.
- Author
-
Castell JV, Gómez-Lechón MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, and Heinrich PC
- Subjects
- Dose-Response Relationship, Drug, Fibrinogen biosynthesis, Humans, Interleukin-1 pharmacology, Interleukin-6, Recombinant Proteins, Tumor Cells, Cultured, Tumor Necrosis Factor-alpha pharmacology, Acute-Phase Proteins biosynthesis, Acute-Phase Reaction, Inflammation, Interleukins physiology, Liver physiology
- Abstract
The three monokines interleukin-1 beta (IL-1 beta), tumor necrosis factor alpha (TNF alpha), and interleukin-6 (IL-6) modulate acute phase plasma protein synthesis in adult human hepatocytes. Only IL-6 stimulates the synthesis of the full spectrum of acute phase proteins as seen in inflammatory states in humans, i.e. synthesis and secretion of C-reactive protein, serum amyloid A, fibrinogen, alpha 1-antitrypsin, alpha 1-antichymotrypsin and haptoglobin are increased while albumin, transferrin and fibronectin are decreased. IL-1 beta as well as TNF alpha, although having a moderate effect on the positive acute phase proteins and inhibiting the synthesis of fibrinogen, albumin and transferrin, fail to induce serum amyloid A and C-reactive protein. These data suggest that IL-6 plays the key role in the regulation of acute phase protein synthesis in human hepatocytes.
- Published
- 1989
- Full Text
- View/download PDF
36. Hepatotoxicity of the opioids morphine, heroin, meperidine, and methadone to cultured human hepatocytes.
- Author
-
Gómez-Lechón MJ, Ponsoda X, Jover R, Fabra R, Trullenque R, and Castell JV
- Subjects
- Cell Survival drug effects, Cells, Cultured, Glutathione analysis, Humans, Liver metabolism, Liver Glycogen metabolism, Serum Albumin biosynthesis, Heroin toxicity, Liver drug effects, Meperidine toxicity, Methadone toxicity, Morphine toxicity
- Abstract
Adult human hepatocytes in chemically defined culture conditions were incubated with morphine, heroin, meperidine, and methadone to investigate their potential hepatotoxicity to human liver. Cytotoxic effects were observed at about 100 times the plasma concentrations required to produce analgesia in human nonaddicts. Concentrations of 1 mM morphine, heroin, and meperidine reduced the glycogen content by 50%, while even 0.2 mM methadone produced a depletion of 70% after 24 h of treatment. Concentrations of 0.8 mM morphine and heroin, 0.4 mM meperidine, and 0.005 mM methadone inhibited the albumin synthesis by about 50% after 24 h of pretreatment. Intracellular glutathione was reduced to 50% of that of controls after 2-3 h of incubation with 2 mM morphine and 1 mM heroin, while 1 mM meperidine and 0.2 mM methadone produced a reduction of about 30% after 6 h incubation. The results show that therapeutic doses of the opioids is unlikely to produce irreversible damage to human hepatocytes, but opiate doses during tolerance or abuse may be a cause of liver dysfunction.
- Published
- 1987
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.